Interferon beta 1a (IFN-beta1a)

Jaundice / Icterus

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S3709
R7933		 Fragoso a (control exposed to Glatiramer), 2013 Neonatal jaundice during pregnancy (anytime or not specified) retrospective cohort exposed to other treatment, sick excluded Adjustment: No 1.37 [0.18;10.35] C
excluded (control group) 		2/29   2/39 4 29
ref
S3711
R7971		 Fragoso a (control unexposed, sick), 2013 Neonatal jaundice during pregnancy (anytime or not specified) retrospective cohort unexposed, sick Adjustment: No 0.81 [0.16;4.02] C 2/29   8/95 10 29
ref
Total 1 studies 0.81 [0.16;4.02] 10 29
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Fragoso a (control unexposed, sick), 2013Fragoso a, 2013 1 0.81[0.16; 4.02]10290%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA0.22.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: control unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0.81[0.16; 4.02]1029 -NAFragoso a (control unexposed, sick), 2013 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 0.81[0.16; 4.02]1029 -NAFragoso a (control unexposed, sick), 2013 1 Tags Adjustment   - No  - No 0.81[0.16; 4.02]1029 -NAFragoso a (control unexposed, sick), 2013 1 All studiesAll studies 0.81[0.16; 4.02]1029 -NAFragoso a (control unexposed, sick), 2013 10.210.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 3709

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed, sick controlsunexposed, sick controls 0.81[0.16; 4.02]1029 -NAFragoso a (control unexposed, sick), 2013 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls 1.37[0.18; 10.35]429 -NAFragoso a (control exposed to Glatiramer), 2013 10.510.01.0